Harvard Heart Letter

Atrial fibrillation, angioplasty drugs approved

Two new medications have been approved by the Food and Drug Administration, one for people with atrial fibrillation and one that works to fight the formation of clots.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In